GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns

By News Health
14 hours Ago

(MedPage Today) — A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded.
Following a review of all available data, the…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938

Author :

Publish date : 2025-06-06 15:06:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mum of boy with PPFIBP1 gene says finding others gave her 'strength'

Novel Anticoagulant Flops for Staving Off Graft Thrombosis in Dialysis Patients

AI-Directed Breast MRI Could Lead to Faster Scan Times Without Affecting Accuracy

Home Testing Doubles Cervical Cancer Screening in Safety-Net Population

Infectious Disease Docs Slam New COVID Vaccine Recommendations

Some Psych Meds Tied to Higher Future Risk of ALS